IP Library › Granted Patent US 7,049,418
Granted Patent B2
US 7,049,418 · App. 09/908,805 · Granted May 23, 2006

Therapeutic and diagnostic agents comprising a SOCS box

Assignee: The Walter and Eliza Hall Institute of Medical Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,049,418
App. No.
09/908,805
Granted
May 23, 2006
Kind
B2
Abstract

The present invention relates generally to therapeutic and diagnostic agents. More particularly, the present invention provides therapeutic molecules capable of modulating signal transduction such as but not limited to cytokine-mediated signal transduction. The molecules of the present invention are useful, therefore, in modulating cellular responsiveness to cytokines as well as other mediators of signal transduction such as endogenous or exogenous molecules, antigens, microbes and microbial products, viruses or components thereof, ions, hormones and parasites.

Claims (12)

1. An isolated nucleic acid molecule which encodes a protein, wherein said protein

(i) comprises a SOCS box, wherein the SOCS box comprises an amino acid sequence having at least 70% identity to SEQ ID NO: 8;

(ii) comprises at least one protein:protein or protein:DNA interacting domain in a region N-terminal of the SOCS box; and

(iii) modulates signal transduction mediated by at least one cytokine selected from the group consisting of granulocyte colony stimulatory factor (G-CSF), interleukin 6 (IL-6) and leukemia inhibitory factor (LIF).

2. The isolated nucleic acid molecule of claim 1 , wherein said SOCS box comprises the sequence as set forth in SEQ ID NO: 8.

3. An isolated nucleic acid molecule which encodes a protein, wherein said protein

(i) comprises a SOCS box, wherein the SOCS box comprises an amino acid sequence having at least 70% identity to SEQ ID NO: 66;

(ii) comprises at least one protein:protein or protein:DNA interacting domain in a region N-terminal of the SOCS box; and

(iii) modulates signal transduction mediated by at least one cytokine selected from the group consisting of granulocyte colony stimulatory factor (G-CSF), interleukin 6 (IL-6) and leukemia inhibitory factor (LIF).

4. The isolated nucleic acid molecule of claim 3 , wherein said SOCS box comprises the sequence as set forth in SEQ ID NO: 66.

5. A nucleic acid molecule according to claim 1 or 3 wherein the signal transduction is mediated by IL-6.

6. An isolated nucleic acid molecule encoding a protein which comprises the sequence as set forth in SEQ ID NO: 8.

Priority Claims (1)
AU PO5117 · Feb 14, 1997 · national
Continuity (4)
Division 0930276900 · Apr 30, 1999
Continuation In Part 0896256000 · Oct 31, 1997
Provisional Application 6008380700 · May 1, 1998
Related Publication 20020147307A1 · Oct 10, 2002